Skip to search formSkip to main contentSkip to account menu

lodenafil carbonate

Known as: bis-(2-(4-(4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-benzenesulfonyl)piperazin-1-yl)-ethyl)carbonate 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

CarbonatesPiperazinesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A Phase I clinical trial of lodenafil carbonate, a new phosphodiesterase Type 5 (PDE5) inhibitor, in healthy male volunteers.
UNLABELLED Lodenafil carbonate is a new phosphodiesterase Type 5 (PDE5) inhibitor used in treatment of erectile dysfunction… 
2011
2011
The management of erectile dysfunction: innovations and future perspectives.
Phosphodiesterase 5 (PDE5) inhibitors are recommended as first line therapy for the treatment of erectile dysfunction (ED). To… 
2011
2011
Development and Validation of a UV-Spectrophotometric Method for the Determination of Lodenafil Carbonate in Tablets and Comparison with the LC-method
A rapid, economical, reproducible, and simple direct UV-spectrophotometric method was developed and validated to assay lodenafil… 
2010
2010
[Cardiovascular repercussion of lodenafil carbonate, a new PDE5 inhibitor, with and without alcohol consumption].
BACKGROUND Millions of men around the world suffer from erectile dysfunction, for which phosphodiesterase 5 inhibitors (PDE-5… 
2009
2009
Lodenafil Carbonate: Reproductive and Developmental Evaluation
Lodenafil, is one new orally‐active, potent and selective inhibitor of the enzyme phosphodiesterase 5 (PDE5) developed in Brazil… 
2007
2007
Pharmacological characterization of the novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum
Methods In functional studies, cavernosal strips were mounted in organ baths for isometric force recording, coupled to a PowerLab… 
2007
2007
MP-12.11: Pharmacological characterization of the novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)